sacubright 100a brand of sacubitril

Sacubitril (24mg), Valsartan (26mg)
Sacubright 50 A brand of sacubitril

SACUBRIGHT 50 is an advanced pharmaceutical formulation that combines two potent medications: Sacubitril (24mg) and Valsartan (26mg). This combination therapy is primarily used to manage heart failure and reduce the risk of hospitalizations related to heart conditions. By working on different pathways, Sacubitril and Valsartan provide a synergistic effect, which significantly improves the quality of life for patients suffering from heart failure with reduced ejection fraction (HFrEF).

The medication is designed to lower blood pressure, reduce the strain on the heart, and prevent the progression of heart failure. In this article, we will explore the composition, key benefits, and important usage information for SACUBRIGHT 50.

Key Features and Ingredients

SACUBRIGHT 50 is composed of two key ingredients:

1. Sacubitril (24mg)
   Sacubitril is a neprilysin inhibitor, which prevents the breakdown of beneficial molecules such as natriuretic peptides. These peptides play a crucial role in reducing fluid retention, blood pressure, and promoting vasodilation, which helps to reduce the strain on the heart. By inhibiting neprilysin, Sacubitril enhances the heart's ability to pump blood effectively and improves overall cardiovascular health.

2. Valsartan (26mg)
   Valsartan is an angiotensin II receptor blocker (ARB). It works by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict and increases blood pressure. By blocking this hormone, Valsartan helps to relax and widen the blood vessels, which leads to a reduction in blood pressure and alleviates the workload on the heart.

Together, these two ingredients work in harmony to improve heart function and manage heart failure symptoms.

Usage

SACUBRIGHT 50 is usually prescribed for patients with heart failure or those at high risk of cardiovascular events. It is typically taken orally, once or twice a day, with or without food, as directed by a healthcare provider. Dosage adjustments may be required based on individual health conditions, particularly kidney function, as both Sacubitril and Valsartan can have effects on renal health.

Patients using SACUBRIGHT 50 should regularly monitor their blood pressure, kidney function, and electrolyte levels to ensure optimal results and avoid complications.

Benefits

The combination of Sacubitril and Valsartan in SACUBRIGHT 50 provides several key benefits for patients with heart failure:

1. Reduced Mortality
   Clinical studies have shown that Sacubitril/Valsartan therapy significantly reduces the risk of death due to cardiovascular disease compared to traditional treatments.

2. Prevention of Heart Failure Progression
   This medication helps to prevent the worsening of heart failure, slowing the decline of the heart's pumping function and reducing symptoms such as shortness of breath, fatigue, and fluid retention.

3. Lower Blood Pressure
   By lowering blood pressure and reducing the load on the heart, SACUBRIGHT 50 contributes to improved cardiovascular health, especially in patients with high blood pressure as a contributing factor to heart failure.

4. Reduced Hospitalizations
   Patients using SACUBRIGHT 50 are less likely to experience heart failure-related hospitalizations, improving their quality of life and reducing the burden on healthcare systems.

5. Improved Heart Function
   The combination of Sacubitril and Valsartan leads to enhanced cardiac output, better heart efficiency, and a reduction in heart failure symptoms over time.

Conclusion

SACUBRIGHT 50, with its powerful combination of Sacubitril (24mg) and Valsartan (26mg), is an innovative treatment option for patients suffering from heart failure. By targeting multiple pathways involved in cardiovascular health, it offers a comprehensive approach to managing heart failure symptoms, reducing hospitalizations, and improving overall heart function. Patients using this medication should follow their healthcare provider’s guidance and undergo regular health checks to ensure optimal results. Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma's product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW